EGUCHI SEIICHIRO
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Assistant Professor
Article types Case report
Language English
Peer review Peer reviewed
Title A Rare Case of Malignant Craniopharyngioma Reactive to Adjunctive Stereotactic Radiotherapy and Chemotherapy: Case Report and Literature Review.
Journal Formal name:World neurosurgery
Abbreviation:World Neurosurg
ISSN code:18788769/18788750
Domestic / ForeginForegin
Volume, Issue, Page 117,pp.332-338
Author and coauthor Nomura Shunsuke†*, Aihara Yasuo, Amano Kosaku, Eguchi Seiichiro, Chiba Kentaro, Komori Takashi, Kawamata Takakazu
Publication date 2018/09
Summary BACKGROUND:Malignant craniopharyngioma or anaplastic craniopharyngioma was first reported in 1987 by Akachi and colleagues. It has malignant clinical and histological features, remarkably rapid progression, atypical pathology like squamous cell carcinoma, and a poor prognosis. To date, 17 cases of malignant craniopharyngioma have been reported, most of which were secondary malignant tumors. In classic benign craniopharyngioma, adjunctive treatment after gross total removal is not necessary, but in cases of malignant tumors, adjunctive treatment is important.CASE DESCRIPTION:Here we report the first case of malignant craniopharyngioma treated with adjunctive gamma knife stereotactic radiosurgery and chemotherapy (carboplatin and etoposide, as well as temozolomide chemotherapy). Treatment effectively controlled progression of the tumor temporarily.CONCLUSIONS:Adjunctive gamma knife stereotactic radiosurgery and chemotherapy for malignant craniopharyngioma affects follow-up strategies, we propose the need for a revision to the World Health Organization classification regarding the evaluation of malignant craniopharyngioma.
DOI 10.1016/j.wneu.2018.05.244
PMID 29933092